Technical Analysis for HTGM - HTG Molecular Diagnostics, Inc.

Grade Last Price % Change Price Change
grade F 2.34 -0.43% -0.01
HTGM closed down 0.43 percent on Monday, May 20, 2019, on 22 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical HTGM trend table...

Date Alert Name Type % Chg
Bollinger Band Squeeze Range Contraction 0.00%
NR7 Range Contraction 0.00%
Lower Bollinger Band Walk Weakness 0.00%
BB Squeeze + Lower Band Touch Range Contraction 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Bollinger Band Squeeze Range Contraction -0.43%
Lower Bollinger Band Walk Weakness -0.43%
BB Squeeze + Lower Band Touch Range Contraction -0.43%

Older signals for HTGM ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
HTG Molecular Diagnostics, Inc. develops and markets a technology platform that facilitates the routine use of complex molecular profiling. The company's HTG Edge platform consists of instrumentation, consumables, and software analytics that are used in sample profiling applications, including tumor profiling, molecular diagnostic testing, and biomarker development. The HTG Edge platform automates the molecular profiling of genes and gene activity using its nuclease protection chemistry on various biological samples. It provides molecular profiling panels targeting late stage drug development programs with potential breakthrough therapies, such as immuno-oncology comprising HTG Edge Immuno-oncology Assay, HTG Edge FGFR Expression Assay, HTG Edge DLBCL Cell of Origin Assay, HTG EdgeSeq microRNA Whole-transcriptome Assay, HTG Edge Top Oncogene Assay, and HTG Edge DMPK Assay. HTG Molecular Diagnostics, Inc. distributes its instruments and consumables directly in the United States; and through distributors or sales agents in parts of Europe, India, and internationally. The company was formerly known as HTG, Inc. and changed its name to HTG Molecular Diagnostics, Inc. in March 2011. HTG Molecular Diagnostics, Inc. was incorporated in 1997 and is based in Tucson, Arizona.
Medicine Biotechnology Biology Nature Tumor Drug Development Molecular Diagnostics Edge Assay Biomarker Microrna
Is HTGM a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 5.46
52 Week Low 2.03
Average Volume 269,567
200-Day Moving Average 3.0771
50-Day Moving Average 2.5238
20-Day Moving Average 2.4765
10-Day Moving Average 2.419
Average True Range 0.1533
ADX 15.86
+DI 17.9398
-DI 22.4632
Chandelier Exit (Long, 3 ATRs ) 2.2001
Chandelier Exit (Short, 3 ATRs ) 2.6699
Upper Bollinger Band 2.6494
Lower Bollinger Band 2.3036
Percent B (%b) 0.11
BandWidth 13.963255
MACD Line -0.0544
MACD Signal Line -0.0393
MACD Histogram -0.0152
Fundamentals Value
Market Cap 26.79 Million
Num Shares 11.4 Million
EPS -2.95
Price-to-Earnings (P/E) Ratio -0.79
Price-to-Sales 5.18
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.48
Resistance 3 (R3) 2.47 2.42 2.45
Resistance 2 (R2) 2.42 2.39 2.42 2.44
Resistance 1 (R1) 2.38 2.36 2.40 2.39 2.44
Pivot Point 2.33 2.33 2.34 2.33 2.33
Support 1 (S1) 2.29 2.30 2.31 2.30 2.24
Support 2 (S2) 2.24 2.27 2.24 2.24
Support 3 (S3) 2.20 2.24 2.23
Support 4 (S4) 2.21